Be sure to review Vitalant’ s latest COVID-19 FAQ prior to your appointment.
​

COVID-19 Antibody Testing Ends June 17

Vitalant is again testing all blood donations for COVID-19 antibodies* in order to produce plasma that could help immunocompromised COVID-19 patients. Antibody testing ends June 17, 2022.

Give blood by June 17, find out your COVID-19 antibody status, and you may be able to help a COVID-19 patient.

SCHEDULE NOW

Wondering about your
COVID-19 antibody status?
Wondering about your COVID-19 antibody status?

 

The details: 

  • Plasma containing high levels of COVID-19 antibodies – called COVID-19 convalescent plasma – can give immunocompromised patients’ immune systems an extra boost to help fight the disease. 
  • Convalescent plasma can be collected from regular whole blood, platelet or plasma donations. Other blood components (red cells, platelets) can still help trauma victims, cancer patients or someone with another serious medical condition. 
  • In December 2021, the Food and Drug Administration (FDA) updated the Emergency Use Authorization (EUA) for COVID-19 convalescent plasma with high antibody levels, specifying its use to treat immunocompromised COVID-19 patients. 
  • Antibody test results will display in your online donor account approximately 2 weeks after your completed donation. Information on how to access your online donor account is available here. 
See what your 2022 antibody test results mean here.

 

*Important information about the antibody test:

 

  • This test only confirms COVID infection in the setting of prior symptoms and a positive test result from an FDA-authorized diagnostic COVID-19 PCR or Antigen oral/nasal swab test
  • For people who have not had a positive diagnostic COVID-19 PCR or Ag oral/nasal swab test, this test provides partial evidence of COVID-19 infection only in those who have not been vaccinated.  A different antibody test is required as an aid to diagnosis of COVID-19 in those who have been vaccinated.
  • While rare overall, a false-positive VITROS Anti-SARS-CoV-2 IgG quantitative test result is uncommon with Reactive+ results, but possible with Reactive results.
  • Higher reactivity has not been demonstrated to confer protection from future infection, but does qualify the donor for CCP donation, subject to additional FDA donor eligibility requirements.

 

Frequently Asked Questions


Vitalant blood donations are currently being tested for COVID-19 antibodies using the Ortho VITROS Anti-SARS-CoV-2 IgG Quantitative Reagent Pack.
You can donate if you’ve had COVID-19 and have been symptom-free for 10 days and meet all other eligibility requirements.
Only completed donations used for patient transfusion are tested for COVID-19 antibodies.
The human body contains about 10 pints of blood and about one pint is given with a blood donation. The antibodies within a blood donation are rapidly replaced by the immune system and will not affect the donor’s immune response to the virus that causes COVID-19 or its variants.